These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

714 related items for PubMed ID: 17936686

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Immunization against a low-frequency human platelet alloantigen in fetal alloimmune thrombocytopenia is not a single event: characterization by the combined use of reference DNA and novel allele-specific cell lines expressing recombinant antigens.
    Kroll H, Yates J, Santoso S.
    Transfusion; 2005 Mar; 45(3):353-8. PubMed ID: 15752152
    [Abstract] [Full Text] [Related]

  • 44. A review of pathophysiology and current treatment for neonatal alloimmune thrombocytopenia (NAIT) and introducing the Australian NAIT registry.
    McQuilten ZK, Wood EM, Savoia H, Cole S.
    Aust N Z J Obstet Gynaecol; 2011 Jun; 51(3):191-8. PubMed ID: 21631435
    [Abstract] [Full Text] [Related]

  • 45. Fetal and neonatal alloimmune thrombocytopenia: evidence based antenatal and postnatal management strategies.
    Winkelhorst D, Oepkes D, Lopriore E.
    Expert Rev Hematol; 2017 Aug; 10(8):729-737. PubMed ID: 28644735
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. [Intracraneal hemorrhage caused by neonatal alloimmune thrombocytopenia. Report of a case and review].
    Lou-Francés G, Pascual-Sánchez M, Jiménez-Fernández M, Echeverría-Matía I, López-Pisón J, Marco-Tello A, Rebage V.
    Rev Neurol; 2017 Aug; 43(2):84-7. PubMed ID: 16838255
    [Abstract] [Full Text] [Related]

  • 48. [Is a non-invasive management allowed for maternofetal alloimmune thrombocytopenia? Experience over a 10-year period].
    Deruelle P, Wibaut B, Manessier L, Subtil D, Vaast P, Puech F, Valat AS.
    Gynecol Obstet Fertil; 2007 Mar; 35(3):199-204. PubMed ID: 17306591
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Epidemiology and management of fetal and neonatal alloimmune thrombocytopenia.
    de Vos TW, Winkelhorst D, de Haas M, Lopriore E, Oepkes D.
    Transfus Apher Sci; 2020 Feb; 59(1):102704. PubMed ID: 31974030
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Fetal/neonatal allo-immune thrombocytopenia (FNAIT): past, present, and future.
    Serrarens-Janssen VM, Semmekrot BA, Novotny VM, Porcelijn L, Lotgering FK, Delemarre FM, Steegers EA.
    Obstet Gynecol Surv; 2008 Apr; 63(4):239-52. PubMed ID: 18348738
    [Abstract] [Full Text] [Related]

  • 56. Fetal and neonatal alloimmune thrombocytopenia: harvesting the evidence to develop a clinical approach to management.
    Symington A, Paes B.
    Am J Perinatol; 2011 Feb; 28(2):137-44. PubMed ID: 20700860
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 36.